An estimated 1.5 million Americans have an abdominal aortic aneurysm (AAA) which can be life-threatening if left untreated. Endovascular aneurysm repair (EVAR) has become the standard of care despite shortcomings in long term results. We are focused on developing innovative technologies to transform EVAR and provide physicians and patients with a definitive solution for AAA treatment.